Clinical Trial Update: Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa [Phase 3]

View source ↗

Summary

Sanofi is running a Phase 3 clinical trial to evaluate avalglucosidase alfa for treatment-naïve infants with Pompe disease; the trial is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• Avalglucosidase alfa (avalglucosidase alfa)

Snippet

Sponsor: Sanofi | Conditions: Glycogen Storage Disease Type II | Phase 3 | Status: ACTIVE_NOT_RECRUITING